Genexine and Merck (MSD) are collaborating to evaluate Genexine’s HPV DNA vaccine GX-188E in combination with Keytruda (pembrolizumab) as a potential treatment for patients with HPV-induced cancers. Under the terms of the agreement, Genexine ... Read more